SCABIVAX CONTAGIOUS PUSTULAR DERMATITIS (ORF) VACCINE

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

CONTAGIOUS PUSTULAR DERMATITIS VACCINE

Available from:

Intervet Ireland Limited

ATC code:

QI04AD01

INN (International Name):

CONTAGIOUS PUSTULAR DERMATITIS VACCINE

Dosage:

Per Cent

Pharmaceutical form:

Suspension for skin scarification

Prescription type:

POM

Therapeutic group:

Ovine

Therapeutic area:

Orf virus vaccine / Contagious Pustular Dermatitis vaccine

Therapeutic indications:

Immunological - Live Vaccine

Authorization status:

Authorised

Authorization date:

2012-06-01

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Scabivax Contagious pustular dermatitis (Orf) vaccine
Suspension for skin scarification
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1
- Minimum Infective Dose
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Suspension for skin scarifacation.
A green-coloured suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep/lambs from 2 days old.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of sheep to reduce the lesions of Orf. Immunity develops in approximately 2 weeks, and the
vaccine provides protection for at least 6 months.
4.3 CONTRAINDICATIONS
Do not use on farms or in flocks where Orf is not a problem.
Do not vaccinate ewes less than 8 weeks before lambing.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Animals may develop Orf subsequent to vaccination but the severity and duration for the disease is usually less than in
non-vaccinated animals.
In a disease outbreak draft off all affected animals, keep in isolation from the main flock. The remainder of the flock
should be vaccinated as soon as possible.
However, some animals may show typical signs of Orf following vaccination due to infection becoming established
before immunity develops. These animals should also be drafted into the isolated group of infected sheep.
per dose (0.03 ml)
Active substance(s)
Contagious pustular dermatitis virus minimum 100 MID
1
Excipient(s)
Green dye (E142)
6.0 micrograms
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 05/06/2012_
_CRN 7011961_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
For a period of 8 weeks subsequent to vaccination, anim